Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study

Alejandra Monserrat Rodríguez-Ramírez, María Teresa Alcántara-Garcés, Sergio Hernández-Jiménez, Ana Cristina García-Ulloa, Denise Arcila-Martínez, Héctor Velázquez-Jurado, Rodrigo...

Full description

Bibliographic Details
Main Authors: Rodríguez-Ramírez AM, Alcántara-Garcés MT, Hernández-Jiménez S, García-Ulloa AC, Arcila-Martínez D, Velázquez-Jurado H, Arizmendi-Rodríguez RE
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/long-term-effects-of-anxiety-on-the-metabolic-control-of-recently-diag-peer-reviewed-fulltext-article-NDT
_version_ 1797944609147453440
author Rodríguez-Ramírez AM
Alcántara-Garcés MT
Hernández-Jiménez S
García-Ulloa AC
Arcila-Martínez D
Velázquez-Jurado H
Arizmendi-Rodríguez RE
author_facet Rodríguez-Ramírez AM
Alcántara-Garcés MT
Hernández-Jiménez S
García-Ulloa AC
Arcila-Martínez D
Velázquez-Jurado H
Arizmendi-Rodríguez RE
author_sort Rodríguez-Ramírez AM
collection DOAJ
description Alejandra Monserrat Rodríguez-Ramírez, María Teresa Alcántara-Garcés, Sergio Hernández-Jiménez, Ana Cristina García-Ulloa, Denise Arcila-Martínez, Héctor Velázquez-Jurado, Rodrigo Eduardo Arizmendi-Rodríguez On behalf of the study group CAIPaDiCentro de Atención Integral del Paciente con Diabetes (CAIPaDi) Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoCorrespondence: María Teresa Alcántara-Garcés, Centro de Atención Integral del Paciente con Diabetes (CAIPaDi) Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Sección XVI Tlalpan, Mexico City, 14080, Mexico, Tel +1 52 55 54870900 (5045), Email teresa.alcantarag@incmnsz.mxIntroduction: Anxiety disorders (AXD) are among the most prevalent mental health conditions in patients with type 2 diabetes (T2D). Previous data have established an association of other psychiatric conditions with poor metabolic control and increased odds of diabetes-related complications. Nonetheless, follow-up information about the effects of AXD on the metabolic control of patients with TD2 is still limited.Objective: Evaluate the effects of AXD on the metabolic parameters of patients with T2D over 12 months of follow-up in a multidisciplinary comprehensive care model.Methods: Prospective study of T2D subjects enrolled in a comprehensive care program with follow-up at 3 and 12 months of treatment. Patients were assessed using the Mini-International Neuropsychiatric Interview and the Hospital Anxiety and Depression Scale (HADS). We registered clinical and metabolic characteristics from each visit. Metabolic parameters over time were analyzed with a mixed model of repeated measures using AXD and time as interaction variables.Results: Our sample included 2703 patients at baseline, and 1161 (43%) subjects continued the follow-up at 12 months. The AXD group had more females, lower age, and fewer years of formal education compared with subjects without AXD at baseline, 3 and 12 months. Patients with AXD also reported higher mean fasting glucose at three months, and higher HbA1c at three and 12 months. Our MMRM for HbA1c reported significant differences over time in subjects with and without AXD. The differences in means between groups increased from 0.17% at three months to 0.31% at 12 months. The variables from the HADS anxiety score, sex, age, years of diagnosis, and insulin treatment were also associated with HbA1c parameters over time.Conclusion: Patients with AXD had the worst glycemic control at 3 and 12 months of follow-up. HbA1c differences in patients with AXD compared with non-AXD subjects increases over time in association with anxiety symptoms.Keywords: diabetes care, psychiatric comorbidity, anxiety, glycemic control
first_indexed 2024-04-10T20:42:27Z
format Article
id doaj.art-311f903a234f4e4ea9712080c1336979
institution Directory Open Access Journal
issn 1178-2021
language English
last_indexed 2024-04-10T20:42:27Z
publishDate 2023-01-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj.art-311f903a234f4e4ea9712080c13369792023-01-24T18:10:57ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212023-01-01Volume 1919720781166Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort StudyRodríguez-Ramírez AMAlcántara-Garcés MTHernández-Jiménez SGarcía-Ulloa ACArcila-Martínez DVelázquez-Jurado HArizmendi-Rodríguez REAlejandra Monserrat Rodríguez-Ramírez, María Teresa Alcántara-Garcés, Sergio Hernández-Jiménez, Ana Cristina García-Ulloa, Denise Arcila-Martínez, Héctor Velázquez-Jurado, Rodrigo Eduardo Arizmendi-Rodríguez On behalf of the study group CAIPaDiCentro de Atención Integral del Paciente con Diabetes (CAIPaDi) Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, MexicoCorrespondence: María Teresa Alcántara-Garcés, Centro de Atención Integral del Paciente con Diabetes (CAIPaDi) Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Sección XVI Tlalpan, Mexico City, 14080, Mexico, Tel +1 52 55 54870900 (5045), Email teresa.alcantarag@incmnsz.mxIntroduction: Anxiety disorders (AXD) are among the most prevalent mental health conditions in patients with type 2 diabetes (T2D). Previous data have established an association of other psychiatric conditions with poor metabolic control and increased odds of diabetes-related complications. Nonetheless, follow-up information about the effects of AXD on the metabolic control of patients with TD2 is still limited.Objective: Evaluate the effects of AXD on the metabolic parameters of patients with T2D over 12 months of follow-up in a multidisciplinary comprehensive care model.Methods: Prospective study of T2D subjects enrolled in a comprehensive care program with follow-up at 3 and 12 months of treatment. Patients were assessed using the Mini-International Neuropsychiatric Interview and the Hospital Anxiety and Depression Scale (HADS). We registered clinical and metabolic characteristics from each visit. Metabolic parameters over time were analyzed with a mixed model of repeated measures using AXD and time as interaction variables.Results: Our sample included 2703 patients at baseline, and 1161 (43%) subjects continued the follow-up at 12 months. The AXD group had more females, lower age, and fewer years of formal education compared with subjects without AXD at baseline, 3 and 12 months. Patients with AXD also reported higher mean fasting glucose at three months, and higher HbA1c at three and 12 months. Our MMRM for HbA1c reported significant differences over time in subjects with and without AXD. The differences in means between groups increased from 0.17% at three months to 0.31% at 12 months. The variables from the HADS anxiety score, sex, age, years of diagnosis, and insulin treatment were also associated with HbA1c parameters over time.Conclusion: Patients with AXD had the worst glycemic control at 3 and 12 months of follow-up. HbA1c differences in patients with AXD compared with non-AXD subjects increases over time in association with anxiety symptoms.Keywords: diabetes care, psychiatric comorbidity, anxiety, glycemic controlhttps://www.dovepress.com/long-term-effects-of-anxiety-on-the-metabolic-control-of-recently-diag-peer-reviewed-fulltext-article-NDTdiabetes carepsychiatric comorbidityanxietyglycemic control
spellingShingle Rodríguez-Ramírez AM
Alcántara-Garcés MT
Hernández-Jiménez S
García-Ulloa AC
Arcila-Martínez D
Velázquez-Jurado H
Arizmendi-Rodríguez RE
Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
Neuropsychiatric Disease and Treatment
diabetes care
psychiatric comorbidity
anxiety
glycemic control
title Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
title_full Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
title_fullStr Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
title_full_unstemmed Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
title_short Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study
title_sort long term effects of anxiety on the metabolic control of recently diagnosed type 2 diabetes patients results from the caipadi cohort study
topic diabetes care
psychiatric comorbidity
anxiety
glycemic control
url https://www.dovepress.com/long-term-effects-of-anxiety-on-the-metabolic-control-of-recently-diag-peer-reviewed-fulltext-article-NDT
work_keys_str_mv AT rodriguezramirezam longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy
AT alcantaragarcesmt longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy
AT hernandezjimenezs longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy
AT garciaulloaac longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy
AT arcilamartinezd longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy
AT velazquezjuradoh longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy
AT arizmendirodriguezre longtermeffectsofanxietyonthemetaboliccontrolofrecentlydiagnosedtype2diabetespatientsresultsfromthecaipadicohortstudy